Objective: Alpha-synuclein protein aggregates and mitochondrial dysfunction have both been described in substantia nigra neurons from patients with idiopathic Parkinson's disease and dementia with Lewy bodies. We explored the relationship between alpha-synuclein pathology and mitochondrial respiratory chain protein levels within single substantia nigra neurons.
Introduction
The pathogenesis of idiopathic Parkinson's disease (iPD) and Dementia with Lewy bodies (DLB) remains unclear. Mitochondrial involvement has been identified as important by several lines of evidence. Defects of the mitochondrial respiratory chain, in particular in activity of complex I, have been described in homogenised substantia nigra (SN) from patients with iPD (1, 2) . High levels deleted mitochondrial DNA (mtDNA) have been reported in the SN of elderly controls and Lewy body disease patients (LBD) (3, 4) . (6, 7) , protection against oxidative stress (7, 8) and reactive oxygen species (ROS) sensing/scavenging (9, 10) .
Whilst mitochondrial dysfunction has a key role to play in the pathogenesis of iPD and DLB, its relationship with the other key pathogenic factor, the accumulation of alpha-synuclein, is less well understood. The accumulation of alpha-synuclein as filamentous inclusions in neurons (Lewy bodies, LBs), and in dystrophic neurites, is the pathological hallmark of both iPD and DLB. In autosomal recessive parkinsonism homozygous mutations generally result in nigral degeneration not associated with LB pathology (5), although LB pathology has been reported in a compound heterozygous individual carrying pink1 mutations (11) and in individuals carrying heterozygous mutations in parkin and pink1 genes (12) (13) (14) .
Recent studies suggest that alpha-synuclein and mitochondria may have closer interactions than once thought and their interaction in vitro coincides with mitochondrial dysfunction (15, Page 5 of 26 16 ). However, much of this data comes from studies examining this relationship in homogenised SN tissue (17) or overexpressing cell culture systems (17) (18) (19) rather than in single human neurons. To test whether mitochondrial abnormalities influence alphasynuclein accumulation we studied individual neurons from the SN in LBD cases. Immunocytochemistry was performed according to (22) with minor modifications. Antigen retrieval was performed in concentrated formic acid followed by high temperature retrieval in 1mM EDTA, pH 8.0 before blocking with 1% normal goat serum. The alpha-synuclein primary antibody (1:30) was then applied for 90 minutes (clone KM51, Novocastra, Leica Biosystems, UK). Biotinylated goat anti-mouse antibodies (Vector Labs, UK) were applied, followed by Vectastain Elite ABC (Vector Labs, UK) and Vectastain Novared substrate (Vector Labs, UK). Following this step sections were stored in TBS overnight at 4ºC.
Patients and methods

Formalin
Immunocytochemistry for mitochondrial proteins (supplementary table 1) was then performed with detection of primary antibodies using the polymer detection system (Menapath kit, A. Menarini Diagnostics, UK).
Dual IHC stained sections were analysed using bright field microscopy and Nuance multispectral imaging (Cri, Woburn, MA). We took low magnification (x4) images of the SN, defined its boundaries and took 15 random images of neuromelanin containing neurons within this area. By using single stain controls for each of the chromogens used in the IHC protocol ( Figure 1 J-M) ; individual spectra for each colour can be created using the Nuance software. Due to the nature of the SN neurons we generated spectra for four 'chromogens', blue for haematoxylin, red for alpha-synuclein, purple for the mitochondrial proteins and yellow/brown for the neuromelanin. These spectra can then be applied to the dual stained For each pigmented neuron we measured the intensity of mitochondrial protein staining (per unit area), and assessed the type/amount of alpha-synuclein pathology. Mitochondrial protein signals were sampled from a region of the neuron not containing neuromelanin, alphasynuclein or the nucleus. Densitometric analysis is an inverse linear scale ranging from 0 (black) to 250 (white). Values were inverted by subtraction from 250, so that more intense staining gave a higher value. All densitometry values were normalised to the mean control value for each protein studied, calculated for cells stained in the same batch. Normalisation was performed by expressing each data point from LBD cases stained at the same time as a percentage of the control mean for that particular protein.
To minimize variation in intensity of immunostaining, we performed staining using one antibody for all patients and controls on the same day, where possible. We also compared porin immunostaining in neurons with no pathology for both controls and patients and showed no difference between the mean values obtained for controls and patients (supplementary figure 1) . Therefore it was reasonable to compare all the data from the LBD cases to the controls and to assume that any changes seen were not due to technical variation. 
Results
Method validation
Absolute quantification of protein expression through the use of densitometric analysis is difficult, but is the only approach allowing us to look at expression in neurons within the same section and compared to controls. Several publications have shown that antibodies to several respiratory chain complexes (including those used in this paper) can detect changes which correlate with a biochemical defect (22, 24, 25). In addition, we have used the same method to explore protein expression in patients with neurodegeneration secondary to primary defects of the mitochondrial genome and are able to show clear defects of protein expression in neurons which correlate with the biochemical defect seen (supplementary figure 2).
Mitochondrial protein levels in SN neurons of normal controls
Using brain sections from normal control subjects we measured the normal expression of different mitochondrial proteins in 5298 single pigmented SN neurons (supplementary figure   3 ). There was minimal evidence of LBs and alpha-synuclein aggregates in these subjects (6.5% of cells contained pathology), this was much lower than in iPD and DLB cases (29% of cells contained pathology (1433/4947 neurons). There was wide variation of staining intensities in normal control individuals for all six mitochondrial proteins studied in this investigation.
Mitochondrial protein levels in SN neurons with and without pathological alpha-synuclein aggregates
The data obtained from both iPD and DLB cases showed the same results, and since iPD and DLB are postulated to be on a clinical spectrum (20) we pooled all the data from these cases to ensure robust statistical significance. From this point forward LBD refers to any data from both iPD and DLB cases. We analysed a total of 4947 single SN neurons from LBD cases.
Porin immunohistochemistry showed that the median and range of the relative mitochondrial density were equal in neurons with and without alpha-synuclein pathology in LBD cases (p value = 0.36) ( Figure 3A ). Therefore any differences in intensity of respiratory chain subunit staining between neurons with and without pathology were unlikely due to changes in overall mitochondrial mass. Staining for complex II 70kDa showed a slight increase in cells with pathology (p value = 0.05) but this was less significant than for other proteins studied. This is relevant since complex II is the only complex of the electron transport chain which contains no subunits encoded by mtDNA. The staining intensity for this subunit is not affect by defects of mtDNA and in fact forms the basis of our COX/SDH activity assay (26).
For all other mitochondrial respiratory chain proteins studied (CI19, CI20, COXI and COXIV), the median intensity of staining was significantly greater in those cells containing alpha-synuclein pathology than in those without (p value =<0.0001) ( 
Complex I deficiency in pigmented LBD SN
Since previous data suggests a role for complex I deficiency in PD, we determined the number of neurons which were deficient for complex I subunits (figure 6 
Discussion
Our data shows that within individual nigral neurons the presence of pathological alphasynuclein aggregates is associated with significantly higher expression of respiratory chain subunits. Alpha-synuclein pathology and deficiencies of mitochondrial respiratory chain subunits, two factors thought to play important roles in the pathogenesis of synucleinopathies, appear to affect different populations of nigral neurons.
Although we only studied protein expression levels in fixed tissues, the expression of a number of the selected proteins reflects the activity of respiratory chain complexes within mitochondria (22). We had expected that mitochondrial dysfunction would lead directly to alpha-synuclein pathology. A deficiency of mitochondrial respiratory chain subunits could lead to ATP depletion which would impair a number of cellular processes, including protein degradation through both chaperone mediated autophagy and the ubiquitin proteasome system (UPS) (30) . Defects of mitochondrial respiratory chain subunits can cause increased free radical production in cell culture (31-34) and could potentially lead to damage of intracellular proteins and increased load on the proteasome.
There are a number of potential explanations for why cells containing alpha synuclein pathology appear to have increased expression of mitochondrial respiratory chain proteins, with no increase in overall mitochondrial density, we discuss three of them. Firstly, it is feasible that mitochondrial dysfunction and alpha-synuclein accumulation provide a toxic 'double-hit' for neurons. Those cells showing both severe mitochondrial dysfunction and alpha-synuclein accumulation are lost, thus explaining why it is extremely rare to find cells with both low levels of mitochondrial protein expression and alpha-synuclein pathology.
However, data from this study examining the relationship between different stages of alpha synuclein accumulation and mitochondrial dysfunction would not support this.
A second possibility is that normal mitochondrial function is required for the accumulation of 
